|Wanbury, the fastest growing pharmaceutical company in India and amongst the top 100 companies as per ORG-IMS, has moved up from 118th rank in 2006 to 83rd in 2007, 64th rank in April 2008, 54th in September 2008 to 47th rank in January 2009 as per ORG-IMS. The formulation business continues to grow aggressively with new brand launches and new divisions being added to the business. .|
Wanbury’s Domestic Formulations has strong presence in Gynaecology, Orthopedics, Surgery and Gastro-intestinal catering to more than 70,000 doctors.
We take great pride in our ability to provide innovative solutions. Over the past few years, we have launched 25 innovative products (including extensions) that were launched for the first time in India by Wanbury. Our pipeline is very strong and we are poised to launch over 50 innovative products over the next couple of years.
One of the key brands, Cpink, launched by Wanbury was awarded ‘Best Brand Launch’ by ORG-IMS in India in 2006-2007. Another key brand Rabiplus was awarded ‘Best Brand launch’ by ORG-IMS in India in 2007-2008. Similarly, Wanbury has carried out some more promising new brand launches each of which, registered sales in excess of Rs 10 crore in the launch year. Over the last couple of years, Wanbury has managed to get 4 of its products viz. Cpink, Rabiplus, Folinine and Adtrol Plus in the ‘Top 4’ brands in its respective segments.
Wanbury has four divisions namely Main division, Osteolife, Surglife and WOW catering to general doctors, orthopedic doctors, surgeons and gynecologists, respectively.